
The Optispan Podcast with Matt Kaeberlein A Geroscience Roundtable: de Grey, Kennedy & Kaeberlein on the Path to Longevity Escape Velocity | 123
Aug 14, 2025
Join longevity pioneers Aubrey de Grey, a biomedical gerontologist focused on rejuvenation strategies, and Brian Kennedy, an expert in aging biology. They share fascinating insights on achieving longevity escape velocity, debating the benefits of damage-repair versus growth-slowing methods. Aubrey discusses his groundbreaking mouse studies and the search for effective combination therapies, while both express cautious optimism about emerging clinical applications. They emphasize the importance of transparency in experimental treatments and the future potential of biological age measurement.
AI Snips
Chapters
Transcript
Episode notes
New Late-Life Rejuvenation Candidates
- Aubrey lists promising late-life rejuvenation candidates: albumin/plasma dilution, OSK gene therapy, IL-11 and CDK5 targets.
- He plans to start new mouse studies at ~18 months to test these orthogonal mechanisms.
Deuterated Fatty Acids As Orthogonal Approach
- Deuterated fatty acids aim to reduce lipid peroxidation by stabilizing bis-allylic hydrogens and may yield outsized effects from partial replacement.
- New catalytic manufacturing cut costs, enabling larger animal studies with promising unpublished results.
Clinic Offerings Often Appear Sketchy
- Aubrey warns many clinic-offered experimental therapies look 'sketchy' and patients often can't judge scientific credibility.
- He stresses credentialed presenters can still overstate confidence, confusing non-scientist audiences.

